GSK2606414 (PERK inhibitor), 1 vial, 5 mg and 1 more item

The University of Nebraska Medical Center, a state agency under the Board of Regents of the University of Nebraska, issued Purchase Order 4800172269 to Selleck Chemicals LLC on January 21, 2026, for the procurement of two pharmaceutical research compounds. The contract encompasses one vial of 4#8C (IRE1 inhibitor) in a 10 milligram concentration and one vial of GSK2606414 (PERK inhibitor) in a 5 milligram concentration, with a total contract value of $344. Delivery is scheduled for January 27, 2026, at UNMC Shipping and Receiving located at 601 South Saddle Creek Road, Omaha, Nebraska, under F.O.B. destination terms with freight prepaid.

Selleck Chemicals LLC, the prime contractor based in Houston, Texas, is required to acknowledge acceptance of the purchase order within 10 days of issuance and include the purchase order number on all packages, invoices, and related documentation. Payment terms are established at Net 30, with the University of Nebraska providing Nebraska State Treasury warrants as the payment mechanism. The procurement is governed by the Standard Terms of Purchase unless otherwise specified by separate agreement between the vendor and the Board of Regents of the University of Nebraska.